(Press-News.org) Speaking at the UK National Stem Cell Network conference in York later today (31 March), Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia (CML) in which a small number of cancer cells persist despite effective therapy thus preventing cure.
CML is a type of blood cancer caused by the infamous "Philadelphia Chromosome" genetic abnormality. It is usually treated using a class of drugs called Tyrosine Kinase Inhibitors and in the majority of cases this treatment is successful, with around 90% of patients recovering from the disease. However in the majority of patients a subset of cancer cells – CML stem cells – are resistant to Tyrosine Kinase Inhibitors.
"At the moment we are working with 9 patients who still have low level evidence of CML despite Tyrosine Kinase Inhibitor treatment. They are helping us to test the use, in principle, of a new type of drug that specifically deals with the resistant CML stem cells," said Professor Holyoake.
"The drug we are using in the trial is hydroxychloroquine – a well established antimalarial drug that has been used commonly since the 1950s and is also used in rheumatoid arthritis. This will allow us to test the principle of using similar drugs to treat CML patients.
"Unfortunately hydroxychloroquine may not be suitable for very long term treatment because of side effects. In particular there is a very low risk of temporary or permanent eye problems. In our trial the patients will take the drug for up to 12 months with very close monitoring of their eye health, which will allow us to intervene at the very earliest sign of an adverse effect," Professor Holyoake continued.
The patients in the trial have already taken a Tyrosine Kinase Inhibitor drug for at least a year, which has reduced the number of cancer cells in their blood to a very low level.
Professor Holyoake's team discovered that CML stem cells avoid the impact of Tyrosine Kinase Inhibitor treatments by going into a state called autophagy in response to the drug. This means that they begin to shut down and use nutrients from within the cell to survive in what is effectively suspended animation. In this state the drug cannot kill them and so later they can initiate a resurgence of the disease. Hydroxychloroquine has been shown to kill cells that are undergoing autophagy and the trial is designed to test whether this is a potential route for treatment in patients.
Professor Holyoake concluded "Although hydroxychloroquine probably isn't the final answer for treating resistant CML stem cells, we are aware that there is interest from the pharmaceuticals industry in developing new drugs that target cells undergoing autophagy. We are therefore very hopeful that once we can prove that in principle this approach works, it could lead relatively quickly to a new treatment for patients for whom Tyrosine Kinase Inhibitors don't provide a full cure."
### END
New approach to leukemia chemotherapy -- is a cure in sight?
2011-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Diet-exercise combo best for obese seniors
2011-03-31
For obese seniors, dieting and exercise together are more effective at improving physical performance and reducing frailty than either alone.
The research, by a team at Washington University School of Medicine in St. Louis, is reported March 31 in The New England Journal of Medicine.
Older adults who are obese face severe health risks, including high blood pressure, heart disease and diabetes, which can be compounded by a lack of mobility.
"We wanted to tease apart the effects of dieting and exercise in older people who are obese," says principal investigator Dennis ...
Beyond Workers' Comp: Employer Liability for Serious Injuries
2011-03-31
Most of the time when employees are injured on the job in Florida, workers' compensation provides the employee's only legal recourse.
Generally, the workers' compensation insurance company pays for medical treatments and lost wages, regardless of whether or not the employer was truly responsible for the injury. In exchange for not having to prove fault, workers are not allowed to pursue personal injury lawsuits.
In some cases this is a reasonable balance. When an on-the-job accident results in a loss of life, though, this balance becomes more difficult to justify.
To ...
Attacking bowel cancer on 2 fronts
2011-03-31
Stem cells in the intestine, which when they mutate can lead to bowel cancers, might also be grown into transplant tissues to combat the effects of those same cancers, the UK National Stem Cell Network (UKNSCN) annual science meeting will hear today.
Professor Nick Barker of the Institute of Medical Biology in Singapore will explain how he and his team identified that the stem cells which are crucial to maintaining a healthy intestine are also the site at which bowel cancers first begin, and how he also hopes to use healthy stem cells to regenerate tissues to help patients ...
UT Southwestern research advances fight against kidney cancer
2011-03-31
DALLAS – March 31, 2011 – Researchers at UT Southwestern Medical Center have discovered genetic pathways to starve selectively kidney cancer cells.
Two separate studies indicate that both rare and common cases of kidney cancer may be susceptible to a new class of drugs that inhibits cancer cells from generating the energy needed to survive. In one study, available online and scheduled for the May 5 issue of the journal Oncogene, researchers found that inactivating the gene von Hippel-Lindau (VHL) in mice blocked cells from using oxygen to provide energy to the cell, forcing ...
New clinical practice guidelines developed for juvenile idiopathic arthritis
2011-03-31
ATLANTA – The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal of broad acceptance within the rheumatology community.
Created as a guide for health care providers, the guidelines focus on the initiation and safety monitoring of multiple medications used in the treatment of JIA, including:
Non-steroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, and many others)
Intraarticular glucocorticoid ...
Teacher's Guilty Plea Illustrates Subtleties In Utah's Sex Crimes Laws
2011-03-31
In early February, a Davis County charter school drama teacher pleaded guilty to forcible sexual abuse, a second-degree felony. According to the allegations, the teacher had given an underage girl rides home and fondled her on at least two occasions, and while he was charged with two counts of forcible sexual abuse, one count was dropped by the prosecutor in exchange for a guilty plea.
As a second-degree felony, forcible sexual abuse carries a possible sentence of one to 15 years in prison, and a fine of up to $10,000. However, the prosecutors in the office of the Davis ...
Research explores link between asthma and smoking
2011-03-31
New research out of the University of Cincinnati suggests that being diagnosed with asthma is significantly associated with a greater risk for a lifetime history of daily smoking and nicotine dependence. The findings are reported in the online preview issue of the Journal of Health Psychology.
The article is authored by Alison McLeish, a UC assistant professor of psychology, along with Jesse Cougle, assistant professor of psychology at Florida State University, and Michael Zvolensky, a psychology professor at the University of Vermont. The study analyzed data from the ...
Being in a good mood may lead to poor memory
2011-03-31
Most people have had trouble remembering something they just heard. Now, a University of Missouri researcher found that forgetfulness may have something to do with being in a good mood. Elizabeth Martin, a doctoral student of psychology in the College of Arts and Science, has found that being in a good mood decreases your working memory capacity.
"Working memory, for example, is the ability to recall items in a conversation as you are having it," Martin said. "This explains why you might not be able to remember a phone number you get at a party when you are having a ...
US earthquake resilience needs strengthening, says new report
2011-03-31
WASHINGTON — A new National Research Council report presents a 20-year road map for increasing U.S. resilience to earthquakes, including a major earthquake that could strike a highly populated area. The report was mostly written prior to the March 11 earthquake in Japan, but the committee of experts who authored it noted that the Japanese experience is a reminder of the devastation that can occur even in a country acknowledged as a leader in implementing earthquake-resilience measures.
In recent decades, destructive earthquakes in the U.S. have only been moderate to ...
Study reveals no impact of age on outcome in chronic myeloid leukemia patients treated with imatinib
2011-03-31
(WASHINGTON, March 30, 2011) – While the median age at diagnosis for chronic myeloid leukemia (CML) is over 60 years old and incidence increases dramatically with age,limited data are available about the long-term outcome for older patients treated with imatinib, the standard first-line therapy used to treat CML. Results from a study published today in Blood, the Journal of the American Society of Hematology, reveal that age does not affect response to imatinib and study investigators conclude that overall survival for CML is similar in older and younger patients treated ...